News
Zepbound beats Wegovy for weight loss
Digest more
Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results